BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 6618428)

  • 1. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
    Falsetti L; Scagliola P; Turla R; Voltolini AM
    Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.
    Falsetti L; Voltolini AM; Crosignani PG; Lotti G; Travaglini P; Faglia G; Cianci A; Palumbo G; Praga C; Pontiroli AE
    Gynecol Obstet Invest; 1982; 13(2):108-16. PubMed ID: 7035305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
    Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
    Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
    Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
    Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 9. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
    Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
    Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
    Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G
    Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment in the hyperprolactinemic anovulatory syndrome].
    Justus B; Richter B; Seiler E; Held HJ; Köhler K; Schaps P
    Zentralbl Gynakol; 1985; 107(21):1296-9. PubMed ID: 4082817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperprolactinemic amenorrhea with Metergoline.
    Bohnet HG; Kato K; Wolf AS
    Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor.
    Burry KA; Schiller HS; Mills R; Harris B; Heinrichs L
    Obstet Gynecol; 1978 Jul; 52(1 Suppl):19S-22S. PubMed ID: 683637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
    Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.